These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 31727671)

  • 1. Genomics and Targeted Therapies in Gastroesophageal Adenocarcinoma.
    Nagaraja AK; Kikuchi O; Bass AJ
    Cancer Discov; 2019 Dec; 9(12):1656-1672. PubMed ID: 31727671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress and challenges in HER2-positive gastroesophageal adenocarcinoma.
    Zhao D; Klempner SJ; Chao J
    J Hematol Oncol; 2019 May; 12(1):50. PubMed ID: 31101074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ctDNA analysis in the personalized clinical management of gastroesophageal adenocarcinoma: turning hope into reality.
    Salati M; Venetis K; Fassan M; Malapelle U; Pagni F; Sajjadi E; Fusco N; Ghidini M
    Future Oncol; 2021 Nov; 17(33):4607-4618. PubMed ID: 34406032
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Klempner SJ; Madison R; Pujara V; Ross JS; Miller VA; Ali SM; Schrock AB; Kim ST; Maron SB; Dayyani F; Catenacci DVT; Lee J; Chao J
    Oncologist; 2019 Nov; 24(11):1462-1468. PubMed ID: 31249137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic Alterations and Targeted Therapy in Gastric and Esophageal Adenocarcinoma.
    Pectasides E
    Clin Ther; 2016 Jul; 38(7):1589-99. PubMed ID: 27041412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards precision oncology for HER2 blockade in gastroesophageal adenocarcinoma.
    Gambardella V; Fleitas T; Tarazona N; Cejalvo JM; Gimeno-Valiente F; Martinez-Ciarpaglini C; Huerta M; Roselló S; Castillo J; Roda D; Cervantes A
    Ann Oncol; 2019 Aug; 30(8):1254-1264. PubMed ID: 31046106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on metastatic gastric and esophageal cancers.
    Shah MA
    J Clin Oncol; 2015 Jun; 33(16):1760-9. PubMed ID: 25918288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma.
    Pectasides E; Stachler MD; Derks S; Liu Y; Maron S; Islam M; Alpert L; Kwak H; Kindler H; Polite B; Sharma MR; Allen K; O'Day E; Lomnicki S; Maranto M; Kanteti R; Fitzpatrick C; Weber C; Setia N; Xiao SY; Hart J; Nagy RJ; Kim KM; Choi MG; Min BH; Nason KS; O'Keefe L; Watanabe M; Baba H; Lanman R; Agoston AT; Oh DJ; Dunford A; Thorner AR; Ducar MD; Wollison BM; Coleman HA; Ji Y; Posner MC; Roggin K; Turaga K; Chang P; Hogarth K; Siddiqui U; Gelrud A; Ha G; Freeman SS; Rhoades J; Reed S; Gydush G; Rotem D; Davison J; Imamura Y; Adalsteinsson V; Lee J; Bass AJ; Catenacci DV
    Cancer Discov; 2018 Jan; 8(1):37-48. PubMed ID: 28978556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Her-2/neu gene amplification and over-expression in stomach and esophageal adenocarcinoma: from pathology to treatment.
    Maresch J; Schoppmann SF; Thallinger CM; Zielinski CC; Hejna M
    Crit Rev Oncol Hematol; 2012 Jun; 82(3):310-22. PubMed ID: 21783379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How Can Gastric Cancer Molecular Profiling Guide Future Therapies?
    Corso S; Giordano S
    Trends Mol Med; 2016 Jul; 22(7):534-544. PubMed ID: 27260398
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Zhang L; Hamdani O; Gjoerup O; Cho-Phan C; Snider J; Castellanos E; Nimeiri H; Frampton G; Venstrom JM; Oxnard G; Klempner SJ; Schrock AB
    JCO Precis Oncol; 2022 Jan; 6():e2100330. PubMed ID: 35050711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology.
    Bartley AN; Washington MK; Ventura CB; Ismaila N; Colasacco C; Benson AB; Carrato A; Gulley ML; Jain D; Kakar S; Mackay HJ; Streutker C; Tang L; Troxell M; Ajani JA
    Am J Clin Pathol; 2016 Dec; 146(6):647-669. PubMed ID: 28077399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Spatial Heterogeneity Within Nonmetastatic Gastroesophageal Adenocarcinomas and Survival.
    Chao J; Bedell V; Lee J; Li MS; Chu P; Yuan YC; Zhao D; Klempner SJ; Lin RJ
    JAMA Netw Open; 2020 Apr; 3(4):e203652. PubMed ID: 32338752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligometastatic Gastroesophageal Adenocarcinoma: Molecular Pathophysiology and Current Therapeutic Approach.
    Jung JO; Nienhüser H; Schleussner N; Schmidt T
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Novel Therapeutic Agents in the Treatment of Patients with Gastroesophageal and Gastric Adenocarcinoma.
    Anandappa G; Chau I
    Hematol Oncol Clin North Am; 2017 Jun; 31(3):529-544. PubMed ID: 28501092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging role of immunotherapy in gastric and esophageal adenocarcinoma.
    Bockorny B; Pectasides E
    Future Oncol; 2016 Aug; 12(15):1833-46. PubMed ID: 27166503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastroesophageal cancer: Navigating the immune and genetic terrain to improve clinical outcomes.
    Jones JO; Smyth EC
    Cancer Treat Rev; 2020 Mar; 84():101950. PubMed ID: 31918022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress and challenges in gastroesophageal cancer.
    Serra O; Smyth EC; Lordick F
    Curr Probl Cancer; 2020 Dec; 44(6):100590. PubMed ID: 32451067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the MET Pathway in Gastric and Oesophageal Cancers: Refining the Optimal Approach.
    Lee J; Tran P; Klempner SJ
    Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):e35-44. PubMed ID: 26880063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome wide single cell analysis of chemotherapy resistant metastatic cells in a case of gastroesophageal adenocarcinoma.
    Hjortland GO; Meza-Zepeda LA; Beiske K; Ree AH; Tveito S; Hoifodt H; Bohler PJ; Hole KH; Myklebost O; Fodstad O; Smeland S; Hovig E
    BMC Cancer; 2011 Oct; 11():455. PubMed ID: 22014070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.